Medistim ASA ( (DE:MD1) ) has issued an update.
Medistim ASA has been actively repurchasing its shares as part of a buyback program announced in March 2025. As of April 11, 2025, the company has acquired 61,382 shares, with recent purchases totaling 9,201 shares at an average price of NOK 164.9748. This initiative reflects Medistim’s strategic financial management and could potentially enhance shareholder value by reducing the number of shares outstanding.
More about Medistim ASA
Medistim ASA operates in the medical technology industry, specializing in products and services for intraoperative ultrasound imaging and quality assessment. The company focuses on providing solutions that enhance surgical procedures, particularly in cardiovascular and vascular surgery.
YTD Price Performance: 7.94%
Average Trading Volume: 223
Technical Sentiment Signal: Strong Buy
Current Market Cap: €244.2M
See more insights into MD1 stock on TipRanks’ Stock Analysis page.